Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), explains how COA plays a role in supporting practices in preparing for Oncology Care Model.
Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), explains how COA plays a role in supporting practices in preparing for Oncology Care Model.
Transcript
How has COA played a role in helping smaller practices prepare for OCM?
We’re trying to create a platform for dialogue. What we’ve found historically—even Medicare, for example, is 50 years, it’s the same program over and over again—payers do the same thing over and over again. Even when you’re an employer and you’re like, "Here’s your benefit package," and you’re like, "Ahh" or "It’s okay, but the premiums are going up." We got to change this concept because we’re just going in the opposite direction.
So the notion of this program, and we have been working on reform now for 6 or 7 years, the [COA Payer Exchange Summit] is a platform is to engage the others. So if you’re part of a care team, the price of admission you must bring a payer or employer and if you’re a payer or employer looking for options you got to bring someone in from a care team. The concept is helping to bring down the walls and it’s exciting because we’re in a place where we’re talking about a place where we’ve never talked before. We haven’t figured it out yet but we’re making progress.
If you look at 6 years ago, the buzzword was pathways, pathways, pathways. It became a component, but it’s not the component. Which is good. There’s other things and we continue to get smarter about what we think’s important in care, in quality, in value and we’re starting to agree on come components. Now the trick is let’s do it efficiently, so it’s the same model, we’re just changing how it’s looked. We have to change optics because there’s still those little fires that pop up, that says, "Here’s what we’re doing," and their motive and their incentive or their understanding is just way off base. So we have a lot of education to do.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More
Early Intervention, Targeted Strategies Needed to Improve Disparities, Survival in Patients With IPF
October 17th 2024Two posters presented at the CHEST 2024 annual meeting highlighted the importance of addressing socioeconomic disparities and identifying clinical predictors to improve outcomes and survival rates among patients with idiopathic pulmonary fibrosis (IPF).
Read More